An Open-label, Multi-centre, Randomised, Comparative Study of the Immunogenicity and Safety of an Inactivated Split-Virion Influenza Vaccine administered by Intradermal Route (Flu-ID 15?g) versus an Inactivated adjuvanted Influenza Vaccine administered by
Read time: 1 mins
Last updated:31st Jul 2007
To demonstrate that the influenza vaccine administered by intradermal (ID) route at the dose of 15?g is at least as immunogenic as the adjuvanted influenza vaccine administered by intramuscular (IM) route at the same dosage in term of HA antibody titres for the three strains at Day 21 post-vaccination.
|Study start date||2007-07-31|